tiprankstipranks
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
US Market
VRDN
Viridian Therapeutics
RESEARCH TOOLSreports

Viridian Therapeutics (VRDN) Stock News & Sentiment

1,506 Followers
3 Best Trending Stocks, According to Analysts – 4/7/2026
Premium
Market News
3 Best Trending Stocks, According to Analysts – 4/7/2026
8d ago
AMGN
NBIX
Viridian: Pullback Seen as Overdone as Veligrotug Convenience and TED Portfolio Underscore Buy Rating
Premium
Ratings
Viridian: Pullback Seen as Overdone as Veligrotug Convenience and TED Portfolio Underscore Buy Rating
8d ago
VRDN
Buy Rating on Viridian: Elegrobart’s Convenience Edge and Overdone Share Price Pullback in Thyroid Eye Disease
Premium
Ratings
Buy Rating on Viridian: Elegrobart’s Convenience Edge and Overdone Share Price Pullback in Thyroid Eye Disease
8d ago
VRDN
Viridian: Buy Rating Backed by Differentiated Elegrobart Profile and Growth Potential in a $2B Thyroid Eye Disease Market
Premium
Ratings
Viridian: Buy Rating Backed by Differentiated Elegrobart Profile and Growth Potential in a $2B Thyroid Eye Disease Market
16d ago
VRDN
Viridian Therapeutics Reports Positive Phase 3 REVEAL-1 Results
Premium
Company Announcements
Viridian Therapeutics Reports Positive Phase 3 REVEAL-1 Results
16d ago
8K
VRDN
Viridian Therapeutics: Well-Funded Late-Stage Pipeline and Imminent Phase 3 Catalysts Support Buy Rating and $42 Target
Premium
Ratings
Viridian Therapeutics: Well-Funded Late-Stage Pipeline and Imminent Phase 3 Catalysts Support Buy Rating and $42 Target
2M ago
VRDN
Strategic Buy on Viridian Therapeutics Ahead of Veligrotug PDUFA and Elegrobart Phase 3 REVEAL‑1 Readout
Premium
Ratings
Strategic Buy on Viridian Therapeutics Ahead of Veligrotug PDUFA and Elegrobart Phase 3 REVEAL‑1 Readout
2M ago
VRDN
More VRDN News >

VRDN News on the Web

Viridian Therapeutics price target lowered to $24 from $32 at Evercore ISI
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (ELVN), Viridian Therapeutics (VRDN) and Soleno Therapeutics (SLNO)
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT) and Viridian Therapeutics (VRDN)
TipRanks News
Neutral
Viridian Therapeutics price target lowered to $36 from $40 at Truist
TipRanks News
Bearish
Viridian Therapeutics price target lowered to $31 from $37 at Wedbush
TipRanks News
Bearish
3 Best Trending Stocks, According to Analysts – 4/7/2026
TipRanks News
Bullish
Viridian Therapeutics price target lowered to $30 from $42 at RBC Capital
TipRanks News
Neutral
AMGN's Subcutaneous Tepezza Scores Phase III Win in Thyroid Eye Disease
Zacks
Bearish

News Score - Last 7 Days

Neutral
VRDN
Sector Average
Media Buzz
This Week3 articles
Weekly Average15.25 articles
News Sentiment
This Week50%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VRDN’s Media Buzz Sentiment?
3 articles about VRDN were published this week. In an average week, 15.25 articles are published.
    What is VRDN’s weekly average amount of articles?
    In an average week, 15.25 articles about VRDN are published.
      What is VRDN’s News Sentiment?
      50% of articles about VRDN were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        TXTMProText Mobility
        ALLOAllogene Therapeutics
        REPLReplimune Group
        IVVDInvivyd
        SLPSimulations Plus
        Showing the stocks with the most bullish news sentiment over the past week